Regulatory T cells in paraneoplastic neurological syndromes

被引:44
作者
Tani, Takashi [1 ]
Tanaka, Keiko [1 ]
Idezuka, Jiro [2 ]
Nishizawa, Masatoyo [1 ]
机构
[1] Niigata Univ, Brain Res Inst, Niigata, Japan
[2] Ojiya Sakura Hosp, Niigata, Japan
关键词
paraneoplastic neurological syndrome; CD4+CD25+regulatory T cell; FOXP3;
D O I
10.1016/j.jneuroim.2008.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Focusing on CD4(+)CD25(+) regulatory T lymphocytes (T-reg), we studied the gene expression of T-reg functional molecules in peripheral blood lymphocytes of patients with paraneoplastic neurological syndrome (PNS), including Lambert-Eaton myasthenic syndrome (LEMS) with small cell lung carcinoma (SCLC) and anti-Hu- or anti-Yo-antibody-positive PNS. T-reg-rich subsets were sorted from the patients' peripheral blood mononuclear cells, and the mRNA expression levels of their functional genes were measured. The expression levels of FOXP3, TGF-beta and CTLA4 mRNA in T-reg-rich subsets of PNS patients were down-regulated compared with that of SCLC patients without PNS. These results suggest that T-reg dysfunction plays a role in PNS development. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:166 / 169
页数:4
相关论文
共 23 条
  • [1] Tumor-specific killer cells in paraneoplastic cerebellar degeneration
    Albert, ML
    Darnell, JC
    Bender, A
    Francisco, LM
    Bhardwaj, N
    Darnell, RB
    [J]. NATURE MEDICINE, 1998, 4 (11) : 1321 - 1324
  • [2] Immune regulation in tumor-bearing hosts
    Baecher-Allan, C
    Anderson, DE
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (02) : 214 - 219
  • [3] Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
    Brunkow, ME
    Jeffery, EW
    Hjerrild, KA
    Paeper, B
    Clark, LB
    Yasayko, SA
    Wilkinson, JE
    Galas, D
    Ziegler, SF
    Ramsdell, F
    [J]. NATURE GENETICS, 2001, 27 (01) : 68 - 73
  • [4] Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma
    Cesana, GC
    DeRaffele, G
    Cohen, S
    Moroziewicz, D
    Mitcham, J
    Stoutenburg, J
    Cheung, K
    Hesdorffer, C
    Kim-Schulze, S
    Kaufman, HL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (07) : 1169 - 1177
  • [5] Quantification of regulatory T cells in patients with systemic lupus erythematosus
    Crispin, JC
    Martínez, A
    Alcocer-Varela, J
    [J]. JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) : 273 - 276
  • [6] Clinical and immunological diversity of limbic encephalitis: A model for paraneoplastic neurologic disorders
    Dalmau, Josep
    Bataller, Luis
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2006, 20 (06) : 1319 - +
  • [7] Signaling triggered by glucocorticoid-induced tumor necrosis factor receptor family-related gene: Regulation at the interface between regulatory T cells and immune effector cells
    Esparza, EM
    Arch, RH
    [J]. FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 1448 - 1465
  • [8] Therapeutic potential of self-antigen-specific CD4+CD25+ regulatory T cells selected in vitro from a polyclonal repertoire
    Fisson, S
    Dielti, F
    Trenado, A
    Billiard, F
    Liblau, R
    Klatzmann, D
    Cohen, JL
    Salomon, BL
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (04) : 817 - 827
  • [9] Foxp3 Programs the Development and Function of CD4+CD25+ Regulatory T Cells (Reprinted from vol 4, pg 330-336, 2003)
    Fontenot, Jason D.
    Gavin, Marc A.
    Rudensky, Alexander Y.
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (03) : 986 - 992
  • [10] Control of regulatory T cell development by the transcription factor Foxp3
    Hori, S
    Nomura, T
    Sakaguchi, S
    [J]. SCIENCE, 2003, 299 (5609) : 1057 - 1061